46Indexed trials
canonical disease area
Bipolar Disorder
Intelligence
Bipolar Disorder intelligence: 46 indexed trials, 11 recruiting studies, 38 sponsors across 34 countries.
11Recruiting
38Sponsors
34Countries
Leading sponsors
University Hospitals Cleveland Medical Center41 recruiting
Massachusetts General Hospital30 recruiting
Sumitomo Pharma America, Inc.20 recruiting
University of California, Los Angeles21 recruiting
Otsuka Pharmaceutical Development & Commercialization, Inc.20 recruiting
Bjorn H. Ebdrup11 recruiting
Biohaven Therapeutics Ltd.10 recruiting
Alexza Pharmaceuticals, Inc.10 recruiting
Mary Phillips, MD MD (Cantab)10 recruiting
Hospital de Clinicas de Porto Alegre10 recruiting
Assiut University10 recruiting
Fondazione Policlinico Universitario Agostino Gemelli IRCCS11 recruiting
Geographic activity
United States30trials
France8trials
Russia4trials
Brazil3trials
Czechia3trials
Canada3trials
India3trials
Italy3trials
Chile2trials
Japan2trials
Denmark2trials
Bulgaria2trials
Leading interventions
Lurasidone2trials
Psychoeducation2trials
risperidone2trials
Antipsychotic1trials
Asenapine1trials
BHV-70001trials
Aripiprazole1trials
Blood draw1trials
CAG Bipola and mood monitoring only1trials
Continuous Theta Burst Stimulation (cTBS)1trials
Curcumin1trials
Bipolar Androgen Therapy (BAT)1trials
Methodology note
This entity is derived from structured ClinicalTrials.gov conditions and/or MeSH normalization. Counts reflect the current NeuroRisk indexed corpus and are not guaranteed exhaustive global totals.